Search research articles
Contact Us
Filters
Showing results (171-180 of 274) with videos related to
Page
of 28
Sort By:
Cancer
|
October 26, 2005
Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience
Debora A Paterniti, Moon S Chen, Christine Chiechi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2019
Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)
Sarmad Sadeghi, Susan G Groshen, Denice D Tsao-Wei, et al.
Cancer
|
May 13, 2004
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial
Primo N Lara, Karen Giselle Chee, Jeff Longmate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2007
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
Robert J Motzer, Craig J Nichols, Kim A Margolin, et al.
Anti-Cancer Drugs
|
February 16, 2005
Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial
Primo N Lara, Lisa Y Law, John J Wright, et al.
Cancer Research
|
April 3, 2008
Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer
Oliver Gautschi, Clifford G Tepper, Phillip R Purnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2003
Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504
David R Gandara, Kari Chansky, Kathy S Albain, et al.
Theranostics
|
March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study
Primo N Lara, Paul Frankel, Philip C Mack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327)
Primo N Lara, Kari Chansky, Angela M Davies, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 274) with videos related to
Sort By:
Page
of 28
Cancer
|
October 26, 2005
Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience
Debora A Paterniti, Moon S Chen, Christine Chiechi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2019
Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653)
Sarmad Sadeghi, Susan G Groshen, Denice D Tsao-Wei, et al.
Cancer
|
May 13, 2004
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial
Primo N Lara, Karen Giselle Chee, Jeff Longmate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2007
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors
Robert J Motzer, Craig J Nichols, Kim A Margolin, et al.
Anti-Cancer Drugs
|
February 16, 2005
Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial
Primo N Lara, Lisa Y Law, John J Wright, et al.
Cancer Research
|
April 3, 2008
Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer
Oliver Gautschi, Clifford G Tepper, Phillip R Purnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2003
Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504
David R Gandara, Kari Chansky, Kathy S Albain, et al.
Theranostics
|
March 23, 2021
<i>In vivo</i> fermentation production of humanized noncoding RNAs carrying payload miRNAs for targeted anticancer therapy
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2003
Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study
Primo N Lara, Paul Frankel, Philip C Mack, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327)
Primo N Lara, Kari Chansky, Angela M Davies, et al.
Page
of 28